Released Feb 26, 2025, after the close
10-K filed Feb 26, 2025, 57 days after period end · 0001636422-25-000028
Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$79.61M$79.61M derived+6.0% vs Q4 2023+4.3% vs Q3 2024
Net Income-$20.67M-$20.67M derivedN/M vs Q4 2023N/M vs Q3 2024
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$17,500,000N/M
Operating Cash Flowderived-$3,527,000N/M
Free Cash Flowderived-$3,940,000N/M
Margins · derived
Operating margin-22.0%+21.7 pt vs Q4 2023
Net margin-26.0%+14.4 pt vs Q4 2023
What the release said
The release
Same quarter
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | $79.61M | $75.08M | $69.16M | $64.72M |
| Net Income | -$20.67M | -$30.31M | -$35.78M | -$48.99M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR